Every program begins with a comprehensive consultation with our medical professionals
Csajbk A, Kocsis K, Farag N, Furdan S, Kovcs B, Lovas S, et al
however, Phase 2 results do not guarantee Phase 3 success or regulatory approval
Pricing as of February 2026
For these patients, oral B12 supplementation (1,000-2,000 mcg daily sublingual methylcobalamin) provides comparable B12 repletion without injection
Although some GLP-1RAs can cross the blood-brain barrier (BBB) and may exert neuroprotective effects 48 , the extent and precise mechanisms of their impact on neurodegenerative processes remain unclear